Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportGeneral Clinical Specialties: Endocrinology

Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model

Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman and Leonard Wartofsky
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;
Frank Atkins
1Division of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Douglas VanNostrand
1Division of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shari Moreau
1Division of Nuclear Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenneth Burman
2Division of Endo;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Wartofsky
3Department of Medicine, Washington Hospital Center, Washington, District of Columbia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1217

Objectives: Previously (JNuclMed 2006:47:324P), we reported a bi-exponential function (BF) that could estimate the maximum tolerated activity (MTA) of 131-I for the treatment (tx) of well-differentiated thyroid carcinoma (WDTC). This BF was (1) easier to use than whole body dosimetry (WBD), (2) based on a single measurement of the percent (%) whole body retention (WBR) of 131-I obtained 48 hrs post dosing , and (3) performed after thyroid hormone withdrawal (THW). Since the biokinetics of iodine may be different using rhTSH injections than THW, the objective of this study was to evaluate if the same BF would still apply for patients in whom rhTSH was used. Methods: A review was conducted of our patients (>16 y.o.) who (1) were suspected of recurrent WDTC, and (2) had rhTSH-stimulated WBD between 2/00 and 12/06. The MTA was determined using a modified Benua-Leeper WBD approach. From the WB clearance curve, the %WBR at 48 hrs was interpolated from the closest time points. For comparison, the rhTSH-BF and THW-BF were both calculated assuming MTA/BSA=a*exp(b*R)+c*exp(d*R) where R is the %WBR at 48hrs. The mean and maximum relative differences between the rhTSH-BF and THW-BF were determined over the range of %WBR from 3-25%. Results: Twenty-six patients (19F,7M) were studied. Normalizing the MTA to the body surface area (BSA) essentially removes the gender dependence. The coefficients for both the THW-BF and (rhTSH-BF) are shown in the table. [table] The mean %WBR for rhTSH was 8.8% (range 1.02-40.8%), which was different (P<0.001) from 15.3% (range 2.6-49.8%) for the THW group. Likewise, the mean normalized MTA was also different (P<0.001); 310(rhTSH) vs 226(THW) mCi/m2. However, the two BF are very similar (P<0.01) with a mean % deviation of 3.5% (range -6.6% to +7.6%). Conclusions: Although the biokinetics are different the rhTSH-BF and THW-BF are essentially identical, and the later may be used to help estimate the dosage of 131-I for the tx of WDTC using either THW or rhTSH.


Embedded Image

  • Society of Nuclear Medicine, Inc.
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 48, Issue supplement 2
May 1, 2007
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman, Leonard Wartofsky
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Percent 48-hr whole body retention for estimating maximum tolerated activity of 131-I for the treatment of well-differentiated thyroid cancer: The effect of rhTSH stimulation vs thyroid hormone withdrawal on a bi-exponential dosimetry model
Frank Atkins, Douglas VanNostrand, Shari Moreau, Kenneth Burman, Leonard Wartofsky
Journal of Nuclear Medicine May 2007, 48 (supplement 2) 268P;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

General Clinical Specialties: Endocrinology

  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
  • The correlation between salivary gland uptake in pre- and post-ablative 131I whole body scan and late salivary gland side effect after initial radioactive iodine therapy
Show more General Clinical Specialties: Endocrinology

Endocrinology Posters

  • Low dose I-123 MIBG diagnostic scan is inferior to I-131 MIBG post-treatment scan in detection of neuroblastoma
  • The frequency of vomiting after outpatient I-131 therapy (tx) in patients (pts) with well-differentiated thyroid cancer (WDTC)
  • A comparison of the psychological status in the patients with hyperthyroidism before and after treatment with radioiodine-131
Show more Endocrinology Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire